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CCR and CC chemokine expression in relation to Flt3 ligand-
induced renal dendritic cell mobilization.
Background. We investigated the expression and function of
CC chemokine receptors (CCR) on highly-purified kidney and
blood dendritic cells isolated from mice in which dendritic cells
were mobilized with fms-like tyrosine 3 kinase ligand (Flt3L).
Methods. CCR and CC chemokine expression were de-
termined by RNase protection assay or flow cytometry, and
dendritic cell migratory responses assayed using Transwell
chambers. Chemokine production in renal tissue was detected
by immunofluorescence staining. Trafficking of fluorochrome-
labeled dendritic cells was monitored in vivo.
Results. Freshly-isolated renal dendritic cells expressed
mRNA for CCR1, 2, 5, and 7 and CCR1 and 5 protein. They
did not migrate to inducible chemokines—CCL3 [macrophage
inflammatory protein (MIP)-1a], CCL5 [regulated upon acti-
vation, normal T cell expressed and secreted (RANTES)], or
CCL20 (MIP-3a). Following lipopolysaccharide (LPS) stimula-
tion, the dendritic cells down-regulated CCR1, 2, and 5 expres-
sion, up-regulated or sustained signals for CCR7, and migrated
to the constitutively expressed ligands CCL19 (MIP-3b) and
CCL21 (secondary lymphoid tissue chemokine). Normal kid-
neys expressed weak message for CCL2, 3, and 4, with stronger
signals for CCL5 and 19. Intrarenal CCL5 production was en-
hanced by Flt3L administration, in association with marked
increases in interstitial CD45+ mononuclear cells. Mobilized
blood dendritic cells migrated to CCR2 and CCR5 ligands and
trafficked to renal intertubular sites following adoptive (intra-
venous) transfer. Their migration to the CCR5 ligand MIP-1b
(CCL4) and homing to kidneys of Flt3L-treated recipients were
inhibited by CCR5 antagonism.
Conclusion. These data implicate specific CCR and their lig-
ands in regulation of the dendritic cell constituency of the kid-
ney. CCR5 antagonism inhibits their directed migration and
intrarenal accumulation.
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Dendritic cells are uniquely well-equipped, bone
marrow–derived antigen-presenting cells (APC) that
play critical roles in the initiation and regulation of im-
mune responses [1–5]. Resident in virtually all tissues,
where their predominant function appears to be immune
surveillance, dendritic cells may also be involved in the
maintenance of tolerance to self-Ag [6]. In the normal
steady-state, interstitial dendritic cells continually traf-
fic from peripheral organs, such as the lung or gut, to T
cell areas of secondary lymphoid tissue [7, 8]. In mice,
this migration of immature dendritic cells bearing self-
Ag leads to Ag-specific T cell deletion, associated with
the development of tolerance [9]. Following uptake of
foreign Ag (e.g., microbial products) in the periphery,
dendritic cells lose their ability to capture antigenic mate-
rial, up-regulate surface T-cell costimulatory molecules,
and traffic to draining lymphoid tissue. This migration
step is regulated by chemokines (chemotactic cytokines)
that induce migration via binding to specific cell surface
receptors [10–12]. Although it is recognized that circulat-
ing dendritic cell precursors traffic from the blood into
solid organs in response to chemokine gradients, the un-
derlying mechanisms have not been fully elucidated. In
the kidney, locally secreted chemokines are thought to
medicate leukocyte recruitment during the initiation and
amplification phases of inflammation [13].
Interstitial dendritic cells, such as those present in kid-
ney, play a key role in defense against infection, and it is
likely that intrarenal dendritic cells are critically involved
in protection against renal parenchymal (pyelonephri-
tis) and urinary tract infection. In experimental glomeru-
lonephritis, increased numbers of functional dendritic
cells are found in the tubulointerstitium [14]. Dendritic
cells also constitute a key component of the “passen-
ger leukocyte” population that migrates into the host
following organ transplantation and are regarded as im-
portant instigators of rejection via the direct pathway of
allorecognition [15–18]. Due to difficulties inherent in
the isolation of these rare cells from normal renal tissue,
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little information has been acquired on the expression of
chemokine receptors by kidney dendritic cells, or on the
responses of dendritic cells to chemokines expressed in
renal tissue in health or disease. Mobilization of dendritic
cells into nonlymphoid tissues, such as the liver, by the en-
dogenous hematopoietic growth factor fms-like tyrosine
3 kinase ligand (Flt3L) has permitted detailed character-
ization of dendritic cells in these organs [19–22].
In this study, we describe CC chemokine receptor
(CCR) expression and chemotactic responses of in vivo
mobilized, freshly isolated renal dendritic cells and the
changes that ensue following overnight culture and
lipopolysaccharide (LPS) stimulation. We report that
freshly isolated kidney dendritic cells express mRNA en-
coding CCR1, 2, 5, and 7, and CCR1 and 5 protein. We
also demonstrate that renal dendritic cells maturation in
vitro and in vivo is associated with differential modu-
lation of CCR. Up-regulation of cognate CCR ligands
within kidneys of Flt3L-treated mice and expression of
corresponding receptors on mobilized blood dendritic
cells suggest the interactions that may be important in
determining and modulating the dendritic cell content of
the kidney.
METHODS
Animals
Male C57BL/10J (B10) (H2b) mice, 8 to 12 weeks
of age, were purchased from The Jackson Laboratory
(Bar Harbor, ME, USA). They were housed in the spe-
cific pathogen-free facility of the University of Pittsburgh
Medical Center and provided with Purina rodent chow
(Ralston Purina, St. Louis, MO, USA) and fresh water ad
libitum. Experiments were conducted in accordance with
the National Institutes of Health guide for care and use
of laboratory animals and under an Institutional Animal
Care and Use Committee protocol.
Reagents
Recombinant (r) murine CC chemokines, monocyte
chemotactic protein (MCP)-1 (CCL1), MCP-3 (CCL2),
macrophage inflammatory protein (MIP)-1a (CCL3),
MIP-1b (CCL4), regulated upon activation, normal T
cell expressed and secreted (RANTES) (CCL5), MIP-
3b (CCL19), MIP-3a (CCL20), and secondary lym-
phoid chemokine (SLC) (CCL21) were purchased from
R&D Systems (Minneapolis, MN, USA). Chinese ham-
ster ovary cell-derived human rFlt3L was provided by
the Immunex Corporation (now Amgen, Seattle, WA,
USA). Rabbit polyclonal anti-CCR1 (CKR-1) (H-52)
(directed against the NH2 terminus) and goat poly-
clonal anti-CCR5 (CRK-5) (D-19) (directed against the
COOH terminus) and the appropriate secondary an-
tibodies, goat antirabbit Ig fluorescein isothiocyanate
(FITC) (sc-2012) and donkey antigoat Ig FITC (sc-
2024) were purchased from Santa Cruz Biotechnol-
ogy (Santa Cruz, CA, USA). Neutralizing anti-CCR5
monoclonal antibodies (C34-3448) was purchased from
BD PharMingen (San Diego, CA, USA). RPMI-1640
(Life Technologies, Gaithersburg, MD, USA) was sup-
plemented with 10% vol/vol fetal calf serum (FCS) (Nal-
gene, Miami, FL, USA) and nonessential amino acids,
L-glutamine, sodium pyruvate, penicillin-streptomycin,
and b2-mercaptoethanol (Life Technologies) (referred
to subsequently as “complete medium”). Mouse re-
combinant granulocyte-macrophage colony-stimulating
factor (GM-CSF) was provided by Dr. S.K. Narula
(Schering-Plough Research Institute, Kenilworth, NJ,
USA). Bovine serum albumin (BSA) was purchased
from Sigma Chemical Co. (St. Louis, MO, USA) and
phosphate-buffered saline (PBS) from BioWhittaker
(Walkersville, MD, USA).
Kidney dendritic cell isolation
Dendritic cells were isolated from the kidneys of
mice given the dendritic cells–mobilizing cytokine Flt3L
(10 lg/mouse/day intraperitoneally in PBS) for 10 con-
secutive days. Four kidneys were finely dissected and in-
cubated in 10 mL of complete medium supplemented
with type IV collagenase (1 mg/mL) (Sigma Chemical
Co.), 1 mL trypsin (0.25% wt/vol) (Life Technologies)
and DNase I (Roche, Mannheim, Germany) (0.5 mL of
a 1 mg/mL solution in PBS) in a humidified atmosphere
at 37◦C. After 45 minutes, the digested tissue was passed
through a fine mesh. The nonparenchymal cells in the su-
pernatants of three sequential spins (40 × g) at 4◦C were
pooled and the cells pelleted at 1000 × g. Dendritic cells
were enriched by density gradient separation using 42%
(wt/vol) metrizamide (Sigma Chemical Co.) at 1200 × g
for 30 minutes at 4◦C. CD11c+ cells were then positively
selected with immunomagnetic beads (monoclonal anti-
body clone N418) (Miltenyi Biotech, Auburn, CA, USA)
using the Macs separation system, according to the man-
ufacturer’s instructions. In some experiments, CD11c+
bead isolated cells were incubated overnight in complete
medium supplemented with GM-CSF (4 ng/mL) or LPS
(Escherichia coli serotype 026:B6) (Sigma Chemical Co.)
(50 ng/mL).
Blood dendritic cell isolation
Dendritic cells were isolated from vena caval blood
of Flt3L-treated B10 mice collected into heparinized
containers (VacutainerTM) (Becton Dickinson, Franklin
Lakes, NJ, USA). Red blood cells were lysed in 0.83%
wt/vol NH4Cl solution, the leukocytes pelleted (800 × g)
and washed with ice-cold Ca++-free 0.01 mol/L ethylene-
diaminetetraacetic acid (EDTA) Hank’s balanced salt
solution (HBSS), then CD11c+ cells isolated by
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immunomagnetic bead separation (as above). Dendritic
cell purity was consistently >90%.
Splenic dendritic cell isolation
Dendritic cells were isolated from spleens of Flt3L-
treated B10 mice following collagenase digestion as de-
scribed [23]. Dendritic cell–enriched suspensions (20%
to 30% purity) were obtained by gradient centrifuga-
tion (700 × g) 20 minutes at 4◦C over 16% wt/vol
metrizamide. Thereafter, dendritic cells were washed,
and immunobead-sorted, as described above. Typical pu-
rity of the isolated CD11c+ dendritic cells was >90%.
Flow cytometric analysis
Dendritic cells were first blocked with 10% vol/vol nor-
mal goat serum (Sigma-Aldrich) for 20 minutes at 4◦C,
then stained with either primary antibody (anti-CCR1 or
anti-CCR5) for 30 minutes at 4◦C, followed by appropri-
ate FITC-conjugated secondary antibody (see above) or
with FITC-conjugated anti-CD40, anti-CD80, anti-CD86
or anti-major histocompatibility complex (MHC) class II
(IAb) (BD PharMingen). Cells incubated with appropri-
ate isotype-matched Ig (Santa Cruz Biotechnology) were
used as negative controls. After staining, the cells were
fixed in 2% wt/vol paraformaldehyde and analyzed using
a Coulter Epics Elite flow cytometer (Coulter, Hialeah,
FL, USA) and EXPO 32 software (Applied Cytometry
Systems, Sheffield, UK).
Immunofluorescence staining of renal tissue
Cryostat sections (8 lm) of renal tissue embedded in
Tissue-Tek 22-oxacalcitriol (OCT) (Miles Laboratories,
Elkhart, NJ, USA) were blocked with 10% vol/vol nor-
mal goat serum (30 minutes, 4◦C) rinsed in PBS and incu-
bated with rat antimouse CCL5 (R&D Systems) followed
by cyanine 3 (Cy3)-conjugated goat antirat Igs (Jackson
ImmunoResearch, West Grove, PA, USA) in combi-
nation with biotin antimouse CD45 (Common Leuko-
cyte Antigen) (BD PharMingen) and Cy2-streptavidin
(Jackson ImmunoResearch). Rat irrelevant Ig of the
same isotype as the primary antibody was used as a con-
trol. After rinsing, nuclei were counterstained with 4′,
6-diamidino-2-phenylinolole (DAPI) Molecular Probes,
Eugene, OR, USA).
RNase protection assay (RPA)
RNA was isolated from 5 × 106 immunobead-purified
dendritic cells using a total RNA Isolation kit (BD
PharMingen). RPA was performed as described [24]
using the RiboQuant Multi-Probe RPA System (BD
PharMingen). Custom kits containing cDNAs encoding
mouse CCR1-7 or CCL2, 3, 4, 5, 19, and 20 and the house-
keeping genes L32 and glyceraldehyde-3-phosphate de-
hydrogenase (GAPDH) were used as templates for the
T7 polymerase-directed synthesis of 32P-uridine triphos-
phate (UTP)-labeled antisense RNA probes. Hybridiza-
tion (16 hours at 56◦C) of 5 lg of each target mRNA with
the antisense RNA probe sets was followed by RNase
and proteinase K treatment, phenol-chloroform extrac-
tion, and ammonium acetate precipitation of protected
RNA duplexes. In each RPA, the corresponding anti-
sense RNA probe set was included as a molecular weight
standard. Mouse RNA and RNA degradation controls
were included. For negative controls, yeast tRNA was
used. Samples were electrophoresed on acrylamide-urea
sequencing gels that were dried and exposed to x-ray film
at −80◦C. Densitometric analysis was performed on a GS-
710 calibrated imaging densitometer (Bio-Rad, Hercules,
CA, USA), and signals for specific mRNAs normalized to
signals for GAPDH run on each lane to adjust for loading
differences.
Dendritic cells migration assay
Assays were carried out as described [25, 26] in 24-well
plates (Becton Dickinson). The following recombinant
cytokines were diluted in migration media (MM) (RPMI-
1640 + 0.5% wt/vol BSA) and 600 lL placed in each well:
CCL2, 3, 4, 5, 7, 19, 20, and 21 for measurement of chemo-
taxis. Transwells (Costar, Cambridge, MA, USA) with
8 or 5 lm polycarbonate membrane pore sizes for imma-
ture and mature, respectively, were loaded with 100 lL
dendritic cells (3 × 105 cells/well), placed in the 24-well
plates, and incubated in a humidified atmosphere of 5%
CO2 in air for 2 hours at 37◦C. The Transwells were then
removed and migrated dendritic cells recovered from the
lower wells enumerated using a Coulter Counter (Coul-
ter). Each assay was performed in duplicate, and an aver-
age value used to determine the chemotactic index (ratio
of the number of cells migrated in response to chemokine,
compared to migration to medium alone). Experiments
were performed at least three times.
In vivo tracking of PKH-67-labeled blood dendritic cells
To visualize their in vivo migration, freshly isolated
CD11c+ blood dendritic cells were labeled with a fluores-
cent marker (PKH-67) and injected into normal or Flt3L-
mobilized (10 lg/day for 10 days) B10 recipients. Briefly,
immunobead-sorted dendritic cells were incubated with
10−6 mol/L PKH-67 (SigmaChemical Co.) at room tem-
perature for 5 minutes, then rinsed extensively with PBS.
In some experiments, CCR5 expression was blocked by
incubation of the cells with anti-CCR5 monoclonal anti-
body (BD PharMingen) (10 lg/mL) (30 minutes at 4◦C)
or rat IgG before injection. Viability was determined by
trypan blue exclusion. Four million viable washed den-
dritic cells were injected intravenously via the lateral
tail vein. After 24 hours, the animals were euthanized
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and fluorescent cells (PKH-67–labeled) within the kidney
imaged using a multiphoton laser scanning confocal mi-
croscope system (Coherent Mira Model 900-F) and by
conventional fluorescence microscopy on cryostat sec-
tions. The percentage of migrated dendritic cells in renal
nonparenchymal and metrizamide-enriched spleen cell
suspensions was determined by rare event, flow cytomet-
ric analysis.
Renal function tests
Urinary protein and serum creatinine levels were de-
termined using conventional procedures.
Statistical analysis
Comparisons were made using the two-tailed unpaired
Student t test and analysis of variance (ANOVA), as ap-
propriate. Values of P < 0.05 were considered significant.
RESULTS
Freshly isolated renal dendritic cells express CCR
consistent with immaturity and modulate CCR
expression in response to overnight culture and
LPS stimulation
As described in the Methods section, the endogenous
dendritic cell mobilizing cytokine Flt3L was administered
to B10 mice for 10 days to enhance the recovery of re-
nal interstitial dendritic cells. No significant alterations
in urinary protein or serum creatinine levels (N = 6
mice) were detected after 10 days Flt3L administration
(data not shown). In a typical experiment, approximately
4 × 106/C were isolated from tissue pooled from four
kidneys following immunobead sorting of CD11c+ cells.
This represented an approximate 20-fold increase in den-
dritic cell recovery compared with normal B10 mice (data
not shown). Total RNA was extracted from the freshly
sorted dendritic cells, and expression of gene transcripts
for chemokine receptors examined by RPA. Freshly iso-
lated renal dendritic cells expressed mRNA encoding
CCR2 and 5, with more modest expression of CCR1 and 7
(Fig. 1A and B), a pattern consistent with the phenotype
of immature dendritic cells freshly isolated or propagated
from other tissues [27–29]. Transcripts for CCR3, 4, and 6
were not detected. Concomitant flow cytometric analysis
of freshly isolated renal dendritic cells confirmed expres-
sion of CCR1 and 5 protein (Fig. 1C). After overnight
culture with GM-CSF, or stimulation with LPS, CCR1,
2, and 5 gene (Fig. 1B) and CCR1 and 5 protein prod-
uct expression (Fig. 1D) were markedly down-regulated.
By contrast, CCR7 mRNA expression was strongly en-
hanced in the same cell population (Fig. 1A and B). These
changes are indicative of renal dendritic cell maturation
in response to overnight culture or LPS stimulation.
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Fig. 1. (A) RNase protection assay (RPA) analysis of CC chemokine
receptors (CCR) expression in freshly isolated, immunobead-sorted
CD11c+ immature (i) and lipopolysaccharide (LPS)-stimulated mature
(m) renal dendritic cells. Freshly-isolated renal immature dendritic cells
expressed mRNA for CCR1, 2, 5, and 7. Overnight culture (18 hours)
with either granulocyte-macrophage colony-stimulating factor (GM-
CSF) (data not shown) or LPS induced marked down-regulation of
CCR1, 2, and 5, with striking up-regulation of CCR7. (B) Densitomet-
ric analysis of the effects of overnight LPS stimulation on renal dendritic
cell CCR expression. Overnight culture with LPS induced up-regulation
of CCR7 and concomitant down-regulation of CCR1, 2, and 5. Results
are shown as arbitrary units [signals for specific mRNAs normalized
to signals for glyceraldehyde-3-phosphate dehydrogenase (GAPDH)]
expressed as means ± 1 SD of three separate experiments. (C and D)
Flow cytometric analysis of CCR1 and 5 protein expression (shaded
profiles) on (C) immature (freshly-isolated) and (D), LPS-stimulated
kidney DC. Open profiles denote isotype controls (data are represen-
tative of three separate experiments).
Migratory responses of renal dendritic cells to CC
chemokines are affected by their maturation status
We next examined the functional significance of CCR
expression on renal dendritic cells by examining their in
vitro chemotactic responses to various CC ligands us-
ing Transwell filters. Freshly isolated kidney dendritic
cells did not exhibit significant chemotactic migratory re-
sponses to typical inducible CC chemokines (i.e., CCL2,
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Fig. 2. Representative chemotactic responses of freshly isolated
(immature), overnight-cultured granulocyte-macrophage colony-
stimulating factor (GM-CSF), and lipopolysaccharide (LPS)-
stimulated renal dendritic cells to inflammatory (CCL5) and
constitutively expressed CC chemokines (CCL19 and 21). Dendritic
cell chemotaxis was quantified using Transwell chambers, as described
in the Methods section. Replicate assays were performed and the mean
value (chemotactic index) ± 1 SD is shown. Data are representative of
results obtained from three separate experiments.
3, 5, or 20) (Fig. 2 and data not shown), despite expression
of message for appropriate receptors and reproducible
migration of immature B10 mouse bone marrow–derived
dendritic cells propagated as described [24] to CCL4 and
CCL5 [26]. As expected, however, and consistent with up-
regulation of CCR7 mRNA, the constitutively expressed
chemokines CCL19 and 21, that induce chemotactic mi-
gration of mature murine and human dendritic cells [26,
28–31], elicited striking, concentration-related migration
of the LPS-matured renal dendritic cells. Maximal re-
sponses for each of these chemokines were evident at 1
to 10 nmol/L (Fig. 2). A more modest response to CCL19
and CCL21 was observed for renal dendritic cells cultured
overnight in GM-CSF.
Flt3L administration up-regulates CCL5 expression
in renal tissue
Both normal kidneys and those from Flt3L-treated
mice were examined for the expression of chemokines
known to be relevant to dendritic cells recruitment. RPA
analysis revealed expression of CCL5 and 19, and to a
lesser extent, CCL 2, 3, and 4 gene products within nor-
mal tissue (Fig. 3A and B). Flt3L treatment increased
the expression of each of these chemokines, especially
CCL5, which was expressed at the highest level in re-
sponse to the hematopoietic growth factor. CCL20 ex-
pression was not detected. To ascertain the presence of
CCL5 protein within normal and Flt3L-treated mouse
kidney tissue, two-color immunofluorescence staining of
cryostat sections was performed as described in the Meth-
ods section. CCL5 protein was expressed by endothelial
cells in normal kidneys. Its expression by these cells was
more extensive following Flt3L administration (Fig. 3C
and D). In addition, in Flt3L-treated mice, CD45+ leuko-
cytes were spatially associated with CCL5+ blood vessels
(Fig. 3C).
Blood-borne dendritic cells express CCR1, 2, and 5
mRNA and migrate to CCL2 and 5
Homing of circulating precursor dendritic cells to pe-
ripheral tissues such as the kidney is likely to be deter-
mined by the recognition of tissue-expressed chemokines
by receptors on these cells. We next isolated den-
dritic cells from the blood of Flt3L-treated mice by im-
munobead separation. RPA analysis performed directly
thereafter revealed CCR1, 2, 5, and 7 expression (Fig. 4A
and B). CCR3, 4, and 6 were not detected. In contrast
to their freshly isolated renal dendritic cells counter-
parts, which also expressed signals for CCR1, 2, 5, and 7
(Fig. 1A and B) but did not respond to CCL5 (Fig. 2),
the freshly isolated blood dendritic cells migrated to this
CC chemokine as well as to CCL2, a ligand of CCR2, in
a dose-related fashion (Fig. 4C).
Blood-borne dendritic cells migrate to kidney and spleen
To assess their capacity to migrate in vivo to the kid-
ney or secondary lymphoid tissue, freshly isolated blood
dendritic cells were labeled with the fluorescent cell mem-
brane dye PKH-67 (green) as described in the Methods
section, then injected into normal syngeneic B10 mice
via the lateral tail vein. After 24 hours, the mice were
killed and the blood, kidneys and spleens examined for
the presence of PKH-67–labeled cells by flow cytometry
and laser scanning confocal microscopy. Labeled den-
dritic cells were detected within the kidney and (to a
greater extent) in spleen by both methods (Fig. 5), but
not in blood by flow cytometric analysis (data not shown).
These findings confirm that blood-borne dendritic cells
that express receptors for and migrate in vitro to CC
chemokines traffic in vivo to renal tissue expressing cog-
nate ligands that likely regulate the homing of dendritic
cells to the kidney.
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Fig. 3. CC chemokine expression in kidneys
of normal (untreated) and Flt3L-treated mice.
(A) RNase protection assay (RPA) analysis,
showing the results of three separate exper-
iments. (B) Densitometric analysis of RPA
data shown in (A), indicating up-regulation
of mRNA for each CC chemokine identi-
fied in kidneys of Flt3L-treated animals. Data
are presented as arbitrary units (as described
in the legend to Figure 1) and expressed as
means ± 1 SD. (C and D) Detection of CCL5
by immunofluorescence staining of kidneys
from Flt3L-treated (C) and normal mice (D).
Two-color staining of cryostat sections for
CCL5 (red) and CD45 (leukocyte common
antigen) (green) clearly shows CCL5 stain-
ing by endothelial cells, which is increased in
Flt3L-mobilized animals. Moreover, in Flt3L-
treated mice (C), CD45+ leukocytes are spa-
tially associated with the CCL5+ blood vessels
(coincident staining) (yellow) (×600). DAPI
is 4′, 6-diamidino-2-phenylinolole.
Blocking of CCR5 expression inhibits dendritic cell
migration in vitro and trafficking to normal and
Flt3L-mobilized kidneys
Since ligands for CCR5 were expressed within normal
kidneys and up-regulated following Flt3L administration,
we used a neutralizing anti-CCR5 monoclonal antibody
to test the dependency of dendritic cell migration to one
of its ligands (CCL4, that binds only to CCR5) and also
their in vivo migratory activity, on CCR5. Treatment of
Flt3L-mobilized blood CD11c+ dendritic cells with the
monoclonal antibody significantly reduced the ability of
the cells to migrate to CCL4 in vitro (Fig. 6A) and also
inhibited their capacity to migrate in vivo to interstitial ar-
eas of the kidneys of Flt3L-treated recipients (P = 0.0215)
(Fig. 6B to E).
In vivo LPS administration modulates MHC class II and
CCR expression by intrarenal dendritic cells
Previous studies of murine interstitial renal dendritic
cells have shown that systemic LPS administration in-
duces both their recruitment to (precursor/immature
dendritic cells) and emigration from the kidney (ma-
ture dendritic cells) [32, 33]. To assess its influence on
renal dendritic cell CCR expression in situ, mice were
given 10 lg of LPS intravenously, 4 or 18 hours be-
fore kidney harvest. Flow cytometric analysis of freshly
isolated dendritic cells from these LPS-treated animals
C DControl +PKH DC Control +PKH DC
FITC
0% 0.5% 0.1% 3.0%
Fig. 5. Detection of fluorescent (PKH-67–labeled) B10 blood
dendritic cells (DC) (green) within (A) intertubular area of nor-
mal syngeneic kidney and (B) spleen, by confocal microscopy, 24
hours after their intravenous injection. (C and D) at the same time,
PKH-67–labeled dendritic cells were enumerated within (C) kidney
nonparenchymal cell and (D) metrizamide-enriched splenocyte pop-
ulations by flow cytometry. Both methods indicate that dendritic cell
migration into the spleen was greater than migration into host kidneys.
Data are from one experiment representative of two performed.
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Fig. 4. CC chemokine receptor (CCR) profile of freshly-isolated, in
vivo-mobilized blood dendritic cells and their migratory responses to
CCL5 and CCL2. (A) Expression of mRNA encoding CCR1, 2, 5, and
7 demonstrated by RNase protection assay (RPA). (B) Densitometric
analysis of RPA data in (A), showing comparatively greater expres-
sion of CCR1, 2, and 7 than CCR5. Data are presented as arbitrary
units as described in the legend to Figure 1, and expressed as means
± 1 SD of three separate experiments. (C) Chemotactic responses of
freshly-isolated blood dendritic cells to CCL5 and the CCR2 ligand
CCL2 [monocyte chemoattractant protein-3 (MCP-3)]. Data are rep-
resentative of results obtained from two separate experiments.
revealed a progressive loss of MHC class II (IAb) expres-
sion compared with dendritic cells from normal kidneys.
Expression of CD86 on dendritic cells recovered from the
kidneys was also reduced following LPS administration
(Fig. 7). Consistent with this loss of IAb+ cells was ev-
idence of up-regulation of CCR1, 2, and 5 mRNA ex-
pression on dendritic cells isolated from the kidneys of
LPS-treated mice determined by RPA analysis (Fig. 8).
Up-regulation of CCR7 message in the same cell popu-
lation (Fig. 8) was consistent with up-regulation of this
chemokine receptor on LPS-treated dendritic cells in
vitro (Fig. 1A) and with enhanced renal dendritic cell mi-
gration to constitutive (“homing”) secondary lymphoid
tissue chemokines (CCL19 and CCL21) (Figs. 1 and 3).
The early (4 hours) increase in CCR7 message that pre-
ceded the maximal increases in CCR1, 5 and 2 expres-
sion (at 18 hours), coupled with down-regulation of MHC
class II expression, suggests that cells exhibiting the high-
est levels of CCR7 and IAb may have left the renal
microenvironment between 4 and 18 hours after LPS ad-
ministration. These in vivo data suggest that intrarenal
modulation of CCR is related to trafficking of dendritic
cells from the kidney following their activation and in
response to appropriate chemokine ligands.
DISCUSSION
The recruitment of dendritic cells into parenchymal or-
gans and their migration from these sites, either in the nor-
mal steady state, or under dynamic conditions, determine
the tissue content of these important immunosurveillant
APC. In the present study, we have investigated factors
that, on the one hand, are likely to regulate the recruit-
ment of dendritic cell precursors from blood into renal
tissue and that, on the other, are likely to promote mi-
gration of dendritic cells from the kidney. We report that
the CCR pattern (CCR 1, 2, and 5) of freshly isolated
murine blood and renal dendritic cells is consistent with
that of immature APC, but that of these two populations,
only blood dendritic cells migrate to the inflammatory
chemokines tested. After overnight culture with either
GM-CSF or LPS, renal dendritic cells down-regulate ex-
pression of inducible chemokine receptors (CCR 1, 2,
and 5) and dramatically up-regulate expression of CCR7.
Consistent with these observations, LPS-matured renal
dendritic cells acquire ability to migrate to CCL21 and
CCL19, both of which are CCR7 ligands and are ex-
pressed on high endothelial venules and in secondary
lymphoid tissue, respectively [34–36]. When an in vivo
“danger” signal (the toll receptor 4 ligand LPS) was ad-
ministered systemically to mice, harvested renal dendritic
cells exhibited a rapid, transient increase in CCR7 expres-
sion with a progressive increase in CCR1, 2, and 5 and a
reduction in MHC class II staining. This suggested that,
by 18 hours, mature dendritic cells may have already left
the kidney.
Although the role of chemokines in dendritic cell mi-
gration has been studied extensively (reviewed [10, 11]),
most analyses have been performed using either in vitro–
generated monocyte-derived (human) dendritic cells or
bone marrow–derived (mouse) dendritic cells [12, 28, 30,
37, 38]. Few studies have examined directly the factors
that recruit potential tissue-resident dendritic cells from
the blood into their respective organs, although the skin
is an exception. Thus, Vanbervliet et al [39] have demon-
strated that human CD34+CD1a+CCR6+ Langerhans
cell–committed precursor cells are recruited from the
blood via expression of CCL20 on skin/dermal epithelia.
In this study, we found that despite expressing CCR1,
2, and 5 mRNA, freshly isolated renal dendritic cells did
not exhibit significant chemotactic responses to ligands
known to bind to these receptors. Similar observations
have been made for freshly isolated splenic dendritic cells,
1914 Coates et al: CCR expression and migration of renal dendritic cells
A
Pe
rc
e
n
t i
nh
ib
itio
n
80
70
60
50
40
30
20
10
0
1 nmol/L 10 nmol/L
CCL4
E
40
35
30
25
20
15
10
5
0
N
um
be
r o
f D
C 
(×1
00
0)/
m
m
2  
o
f k
id
ne
y 
se
ct
io
n
Control anti-CCR5
Fig. 6. Blocking of CCR5 expression inhibits dendritic cell (DC) migration. Exposure of Flt3L-mobilized blood dendritic cells to blocking anti-
CCR5 monoclonal antibodies inhibits (A) their in vitro migration to the CCR5 ligand CCL4 and (B to E), their in vivo homing (fluorescent-labeled
dendritic cells) to kidneys of Flt3L-mobilized recipients. (B) Arrow denotes fluorescent (PKH-67–labeled) dendritic cells (green) within a glomerulus,
the center of which is denoted by an asterisk. Arrowhead indicates location of juxtaglomerular apparatus at the vascular pole of the glomerulus;
white lines prescribe the perimeters of blood vessels. (C) PKH-67–labeled dendritic cells (arrow) within the interstitium between convoluted tubules
(∗) (perimeters denoted by white lines) in the cortex. (D) PKH-67–labeled dendritic cells (green) within the medullary interstitium (white lines
denote the perimeters of tubules). (E) Quantitation of migrating dendritic cells in at least nine sections from each kidney of two mice per treatment
group (means ± 1 SD are shown) (magnifications ×400; insets ×1000).
both from normal and Flt3L-mobilized mice [26]. By con-
trast, freshly isolated blood CD11c+ DC did migrate un-
der the same experimental conditions. RPA analysis of
both normal and Flt3L-treated murine kidneys showed
expression of CCL2-4, 5, and 19. A possible explanation
for the failure of the immature kidney dendritic cells to
migrate is that, upon binding of their respective ligands
within renal tissue, CCRs may be desensitized to the at-
tractant effects of specific chemokines [40, 41]. Signal
transduction consequent upon receptor ligation results in
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Fig. 7. Loss of major histocompatibility com-
plex (MHC) class II+ (IAb+) dendritic cells
from the Flt3L-mobilized kidney following
systemic lipopolysaccharide (LPS) adminis-
tration. LPS was injected intravenously, as de-
scribed in the Methods section, and flow cy-
tometric analysis of harvested renal CD11c+
DC performed 4 and 18 hours later. A pro-
gressive reduction in cells expressing surface
CD86 and MHC class II (IAb) is observed.
The data are representative of two experi-
ments performed, with three mice in each ex-
perimental group.
activation of the heterotrimeric G protein, releasing the
bc subunit which activates the phosphoinositide-3 kinase
(PI3-K) and phospholipase C pathways to produce an in-
crease in phosphatidylinositol 3, 4, 5 triphosphate (PIP3)
and intracellular Ca++, respectively. Ultimately, the
protein kinase C pathway is stimulated, and phosphory-
lation of the chemokine receptor by G protein receptor–
coupled kinases occurs, rendering the receptor desensi-
tized to further stimulation [42]. This process is classified
as either homologous or heterogeneous desensitization
(reviewed in [43]).
Homologous desensitization refers to phosphory-
lation-dependent receptor internalization induced by
binding of a ligand to its appropriate receptor. Heterol-
ogous desensitization occurs when chemokine receptor
function is influenced by binding of other unrelated lig-
ands acting through alternative receptors. Notably, CCR5
desensitization has been reported to occur by both ho-
mologous [40, 44] and heterogeneous desensitization
[41]. As CCL4 and CCL5 message was up-regulated in the
kidneys of Flt3L-treated animals (Fig. 3), we hypothesize
that CCR5 might play a role (albeit possibly redundant)
in recruitment of dendritic cells into the kidney. Once
present within renal tissue, CCR5 on these dendritic cells
then would become desensitized, most likely by homol-
ogous desensitization due to high cognate ligand expres-
sion (Fig. 3). Freshly isolated blood dendritic cells showed
relatively low CCR5 mRNA expression compared with
their renal counterparts, suggesting that CCR5 expres-
sion on blood dendritic cells may be low until after expo-
sure to chemotactic ligands/inflammatory signals.
While CCL5 protein expression by endothelial cells
was detected by immunofluorescence staining within the
kidney under normal conditions, it was up-regulated
following Flt3L administration in association with en-
hanced numbers of interstitial CD45+ leukocytes (Fig.
3C). Conceivably, Flt3L may increase CCL5 synthesis by
vascular endothelium, directly or infiltrating leukocytes
may liberate cytokines that up-regulate CCL5 expres-
sion. There is also evidence of renal CCL5 up-regulation
on vascular endothelium, renal epithelium, and infil-
trating mononuclear cells during kidney allograft rejec-
tion [45], and in other pathologic situations. These in-
clude obstructive nephropathy [46] and kidney-specific
metastasis in a murine lymphoma model [47]. Local pro-
duction of CCL5 by renal mesangial cells induced by
other chemokines, such as the CXC chemokines MIP-2
and KC, has been implicated in renal leukocyte infil-
tration and inflammation [48]. The present study doc-
uments the in vitro migration of immature blood den-
dritic cells to CCL5, CCL4, and CCL2, providing one
pathway whereby dendritic cells may enter the renal
parenchyma, able subsequently to acquire and present
antigen (Ag). Furthermore, our data confirm in vivo mi-
gration of CD11c+ blood dendritic cells into the kid-
ney. A likely role for CCR5 ligands in recruitment of
blood-borne dendritic cells into the kidney suggests that
new therapeutic molecules designed to inhibit functions
of specific chemokines might be beneficial in preventing
renal dendritic cell recruitment and indirect alloantigen
(alloAg) presentation thought to be important in patho-
genesis of chronic allograft nephropathy. In the present
experiments, neutralizing anti-CCR5 monoclonal anti-
body inhibited accumulation of dendritic cells in kidneys
of Flt3L-treated mice. This observation is consistent
with the efficacy of anti-CCR5 monoclonal antibodies
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Fig. 8. (A) RNase protection assay (RPA) and (B) corresponding den-
sitometric analysis of CC chemokine receptor (CCR) mRNA expres-
sion in Flt3L-mobilized kidney dendritic cells either before (0 hour) or
4 or18 hours after in vivo exposure to lipopolysaccharide (LPS). At 0
hour, the cells showed a typical immature dendritic cell CCR recep-
tor profile similar to renal dendritic cells freshly isolated from normal
animals. After systemic LPS administration, there was a striking, early
increase in CCR7 expression and a less marked, progressive increase
in expression of CCR1, 2, and 5. Data are presented as arbitrary units,
as described in the legend to Figure 1, and are representative of two
separate experiments that gave similar results.
in blocking ligand-receptor interactions [44] and in sup-
pressing experimental organ allograft rejection [49].
Taken together, the present studies show that den-
dritic cells resident in the kidney express CCR mRNA
typically expressed by (immature) blood dendritic cells.
Their failure to migrate to ligands expressed in normal
and Flt3L-treated mouse kidney may reflect receptor de-
sensitization. By contrast, murine blood dendritic cells do
migrate to these ligands under similar experimental con-
ditions. The data suggest a role for CCL2, CCL4, CCL5,
and other CC chemokines in the recruitment of dendritic
cells from the blood into both normal and Flt3L-treated
mouse kidneys, and of CCL19 and 21 in their migration
(once activated/induced to mature) from renal tissue to
secondary lymphoid organs. Further understanding of the
factors that influence the migratory activities of dendritic
cells to/within the kidney or other parenchymal organs
may allow us to target/manipulate these events to im-
prove outcomes in a variety of clinical conditions.
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